Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Latest Research

Filter Results By

Filter Applied. Clear All

Latest Posts

April 17, 2024 Fact Sheet: Planned Parenthood’s 2022-23 Annual Report Fact Sheet: Planned Parenthood’s 2022-23 Annual Report April 10, 2024 New Study: Abortion Increases Risk of Cardiovascular Diseases New Study: Abortion Increases Risk of Cardiovascular Diseases April 2, 2024 Abortion Reporting: Florida (2023) Abortion Reporting: Florida (2023)
Reset All Filters
Life & the Law

Public Comment: Lozier Institute on CDC’s Notice of Proposed Modifications to Assisted Reproductive Technology Program Reporting

On January 25, 2024, CLI submitted a public comment to the CDC regarding newly proposed modifications related to data collection and reporting from assisted reproductive technology programs and modifications to data validation procedures. In light of the fact that none of these proposed changes recognized the inherent value and dignity of nascent human beings created from ART programs, including IVF, CLI took the opportunity to encourage the CDC to do so and to consider limiting, reporting, or regulating "the number of living embryos destined for research and destruction."

CLI Scholars React to Nature Medicine Study
Chemical Abortion

CLI Scholars React to Nature Medicine Study

Following the release of a study in Nature Medicine, which discussed the “safety and effectiveness” of abortion drugs acquired through telehealth, Tessa Longbons Cox, senior research associate at the Charlotte Lozier Institute, made the following statement:

Maternal & Public Health

Five Facts About “Life-Limiting” Fetal Conditions

Babies prenatally diagnosed with a life-limiting condition often face discrimination. Some continue to refer to these conditions as “lethal” or “fatal” or “incompatible with life.” In such cases abortion is often offered as the only option to families. The fact is, however, that some of these babies may require very minimal medical support after birth or may benefit and be stabilized for further evaluation with medical interventions routinely performed on babies without lethal labels.

Charlotte Lozier Institute Responses to Sage Retractions
General

Charlotte Lozier Institute Responses to Sage Retractions

The Charlotte Lozier Institute (CLI) and associate scholars are facing an unprecedented attack on our research. We believe that because our research has been widely read and cited, including in prominent legal contexts, we are now subject to unprovoked and partisan assault. Sage Publishing, an academic publishing company, retracted three of our studies on February 5, 2024. This action is meritless because, among other things, Sage to this day has advanced no legitimate objection to any findings of the studies.

Maternal & Public Health

Abortion Reporting: Pennsylvania (2022)

Pennsylvania’s 2022 abortion report was published online by the Pennsylvania Department of Health in December 2023. The report shows that abortions increased from the previous year.

Maternal & Public Health

Abortion Reporting: Idaho (2022)

The Idaho Department of Health and Welfare released their annual vital statistics report, showing that abortions declined in 2022 from the previous year.

Maternal & Public Health

Abortion Reporting: Arizona (2022)

Arizona’s 2022 abortion report was published online by the Arizona Department of Health Services in December 2023.

Fetal Tissue, Stem Cells & Bioethics

Stopping the Pain and Saving Lives: Successful Treatments for Sickle Cell Disease

The U.S. Food and Drug Administration (FDA) recently approved not just one, but two new gene therapies for sickle cell disease. The success of adult stem cell therapies continues to demonstrate that the progress of science and medicine need not rely on ethically compromised research and treatment approaches.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image